In a significant stride towards fortifying indigenous manufacturing capabilities and fostering innovation in the pharmaceutical sector, the Technology Development Board (TDB) has entered into an agreement with Alchem Synthon, Mumbai.

The board will provide a loan assistance of Rs. 8.6 crore out of the total project cost of Rs. 19.01 crore for the "Development and Commercialization of Advanced Pharmaceutical Intermediates, Fine & Specialty Chemicals."

The project aims to establish a state-of-the-art manufacturing facility dedicated to large-scale production of Key Starting Materials (KSMs) and Advanced Intermediates, pivotal for Active Pharmaceutical Ingredients (APIs) that comply with stringent quality standards. Additionally, the facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities.

Upon completion, the new manufacturing facility will increase production capacity, targeting an output of 12,000 Kg per month compared to the existing capacity of 1,000 Kg per month. Moreover, the facility will prioritize the synthesis of new intermediates and KSMs, catering to the needs of bulk drug/agrochemical industries that currently rely on imports for these critical chemicals. By increasing domestic production capacity and reducing reliance on imports, the project contributes significantly to the Atmanirbhar Bharat initiative, promoting self-reliance and reducing foreign exchange outflow.

Speaking on the occasion, Rajesh Kumar Pathak, Secretary, TDB stated, "The company's focus on designing novel, non-infringing, and techno-commercially viable processes for manufacturing API Intermediates and Chemicals not only drives niche market growth but also reduces industry dependence on imported Key Starting Materials (KSMs) & Advanced Intermediates. This is crucial for APIs and Specialty & Fine Chemicals, utilized across various sectors such as Polymer Industry & Water Treatment Facilities.”